» Articles » PMID: 16955439

Risk Factors for Neuropsychiatric Symptoms in Dementia: the Cache County Study

Overview
Specialties Geriatrics
Psychiatry
Date 2006 Sep 7
PMID 16955439
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the probability of individual neuropsychiatric symptoms in dementia patients as a function of eight risk factors.

Methods: In the Cache County Study, we administered the Neuropsychiatric Inventory (NPI) to 328 dementia patients at baseline. Approximately 18 months later, we re-administered the NPI to 184 participants available for follow-up. Generalized estimating equation methods were used to model the probability of individual neuropsychiatric symptoms as a function of: gender, age, education, dementia type and severity, APOE status, time of observation, and general medical health.

Results: Women showed increased tendency toward anxiety, [odds ratio (OR) 2.22, 95% confidence interval (CI) 1.31-3.76] and delusions (OR 2.15, CI 1.22-3.78), but older persons of both sexes showed less tendency toward anxiety. Dementia severity increased the tendency toward hallucinations and agitation (OR 2.42, CI 1.81-3.23) and decreased risk of depression. Positive APOE epsilon4 status increased the tendency toward aberrant motor behavior (OR 1.84, CI 1.05-3.22). Among dementia diagnoses, those with Alzheimer's disease showed decreased tendency toward agitation (OR 0.58, CI 0.35-0.95), depression (OR 0.56, CI 0.33-0.96) and disinhibition (OR 0.46, CI 0.24-0.88). Later time of observation increased risk of aberrant motor behavior and delusions, and more serious medical comorbidity increased risk of, agitation, irritability, disinhibition, and aberrant motor behavior.

Conclusions: Gender, age, dementia severity, APOE epsilon4, dementia diagnosis, time of observation, and general medical health appear to influence the occurrence of individual neuropsychiatric symptoms.

Citing Articles

Survival Bias, Non-Lineal Behavioral and Cortico-Limbic Neuropathological Signatures in 3xTg-AD Mice for Alzheimer's Disease from Premorbid to Advanced Stages and Compared to Normal Aging.

Muntsant A, Castillo-Ruiz M, Gimenez-Llort L Int J Mol Sci. 2023; 24(18).

PMID: 37762098 PMC: 10531136. DOI: 10.3390/ijms241813796.


The association of physical activity and behavioral and psychological symptoms among a sample of hospitalized older adults living with dementia.

Drazich B, Boltz M, Kuzmik A, Galik E, Kim N, McPherson R Int J Geriatr Psychiatry. 2023; 38(2):e5885.

PMID: 36734152 PMC: 10495074. DOI: 10.1002/gps.5885.


Prevalence of mild behavioral impairment in patients with mild cognitive impairment.

Kianimehr G, Fatehi F, Noroozian M Acta Neurol Belg. 2021; 122(6):1493-1497.

PMID: 34191260 DOI: 10.1007/s13760-021-01724-z.


Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia.

Wei Y, Schmidt S, Chen C, Fillingim R, Reid M, DeKosky S Alzheimers Res Ther. 2021; 13(1):78.

PMID: 33883028 PMC: 8061026. DOI: 10.1186/s13195-021-00818-3.


Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trials.

Liu K, Borissova A, Mahmood J, Elliott T, Knowles M, Bentham P Alzheimers Dement (N Y). 2021; 7(1):e12157.

PMID: 33816763 PMC: 8010365. DOI: 10.1002/trc2.12157.